» Articles » PMID: 39399135

Management of Severe Colitis and Toxic Megacolon

Overview
Date 2024 Oct 14
PMID 39399135
Authors
Affiliations
Soon will be listed here.
Abstract

Severe colitis is a well-defined condition encompassing several etiologies but is most often caused by severe ulcerative colitis or infection. Severe colitis can evolve into toxic colitis, or toxic megacolon when associated with bowel dilation and systemic manifestations, resulting in a life-threatening scenario where multidisciplinary management is often required. Medical management continues to play an important role in the initial treatment of toxic megacolon. However, timely surgical intervention can be lifesaving.

Citing Articles

Toxic Megacolon: A Sequelae of Clostridioides difficile Infection in a Case of Necrotizing Fasciitis.

Bhargava A, Mahakalkar C, Kshirsagar S, Yachmaneni A Cureus. 2024; 16(1):e53034.

PMID: 38410289 PMC: 10895553. DOI: 10.7759/cureus.53034.

References
1.
Khanna S, Shin A, Kelly C . Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017; 15(2):166-174. DOI: 10.1016/j.cgh.2016.10.024. View

2.
Strong S . Management of acute colitis and toxic megacolon. Clin Colon Rectal Surg. 2011; 23(4):274-84. PMC: 3134807. DOI: 10.1055/s-0030-1268254. View

3.
Jalan K, Sircus W, CARD W, FALCONER C, Bruce C, CREAN G . An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969; 57(1):68-82. View

4.
Peprah D, Chiu A, Jean R, Pei K . Comparison of Outcomes Between Total Abdominal and Partial Colectomy for the Management of Severe, Complicated Clostridium Difficile Infection. J Am Coll Surg. 2018; 228(6):925-930. PMC: 6535364. DOI: 10.1016/j.jamcollsurg.2018.11.015. View

5.
Longo W, Mazuski J, Virgo K, Lee P, Bahadursingh A, Johnson F . Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004; 47(10):1620-6. DOI: 10.1007/s10350-004-0672-2. View